The p38 mitogen-activated protein kinase inhibitor, SB203580, activates the serine/threonine kinase Raf-1 in vascular smooth muscle cells.

被引：0
|
作者：
Daum, G [1 ]
Kalmes, A [1 ]
Clowes, AW [1 ]
机构：
[1] Univ Washington, Dept Surg, Seattle, WA 98195 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A470 / A470
页数：1
相关论文
共 50 条
  • [21] The p38 mitogen-activated protein kinase inhibitor SB203580 can antagonise P2X7 receptor-mediated responses.
    Michel, D
    Thompson, KM
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U112 - U112
  • [22] Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells
    Ahmed Z. Alanazi
    Michelle A. Clark
    Pharmacological Reports, 2020, 72 : 246 - 253
  • [23] Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells
    Ishii, Y
    Sakai, S
    Honma, Y
    LEUKEMIA RESEARCH, 2001, 25 (09) : 813 - 820
  • [24] Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells
    Shin, HJ
    Oh, J
    Kang, SM
    Lee, JH
    Shin, MJ
    Hwang, KC
    Jang, Y
    Chung, JH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) : 18 - 24
  • [25] Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells
    Alanazi, Ahmed Z.
    Clark, Michelle A.
    PHARMACOLOGICAL REPORTS, 2020, 72 (01) : 246 - 253
  • [26] The p38 MAP kinase pathway interacts with Raf-1 serine threonine kinase to transform intestinal epithelial cells
    Du, JG
    Bo, J
    Barnard, JA
    PEDIATRIC RESEARCH, 2003, 53 (04) : 175A - 175A
  • [27] Expression of synphilin-1 in vascular endothelial cells and its enhancement by SB203580, an inhibitor of p38 MAP kinase
    Tamo, W
    Imaizumi, T
    Yoshida, H
    Mori, F
    Fukuda, I
    Wakabayashi, K
    Satoh, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 61 - 61
  • [28] Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase
    Park, MJ
    Park, IC
    Hur, JH
    Kim, MS
    Lee, HC
    Woo, SH
    Lee, KH
    Rhee, CH
    Hong, SI
    Lee, SH
    JOURNAL OF NEUROSURGERY, 2002, 97 (01) : 112 - 118
  • [29] Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α
    Pan, Yun-Xi
    Chen, Ke-Fei
    Lin, Yi-Xing
    Wu, Wei
    Zhou, Xiao-Ming
    Zhang, Xiang-Sheng
    Zhang, Xin
    Shi, Ji-Xin
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 726 - 730
  • [30] Antiischemic effects of SB203580 are mediated through the inhibition of p38α mitogen-activated protein kinase -: Evidence from ectopic expression of an inhibition-resistant kinase
    Martin, JL
    Avkiran, M
    Quinlan, RA
    Cohen, P
    Marber, MS
    CIRCULATION RESEARCH, 2001, 89 (09) : 750 - 752
12345